Guardant Health AMEA CEO, Mr Simranjit Singh, will be sharing his views on the trends and future of precision oncology at the 2019 BIO Asia-Taiwan Conference and Exhibition at 9am on 25 July in Taipei. The venue of the talk is as follows: 3F, Building A, CTBC Financial Park, Ballroom A. His talk will be focussed on how we are moving away from the traditional trial and error approach to one of treatment selection for patients with advanced cancer through comprehensive genomic profiling.